Advertisement

Topics

"Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia" Drugs and Medication Database

10:09 EST 16th February 2019 | BioPortfolio

Here are the most relevant "Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia" Drugs and Medications that we have found in our database.

More Information about "Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia" on BioPortfolio

We have published hundreds of Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia news stories on BioPortfolio along with dozens of Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia Clinical Trials and PubMed Articles about Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia Companies in our database. You can also find out about relevant Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia Drugs and Medications on this site too.

Showing "Safety Effectiveness Azidothymidine Positive Patients With Hemophilia" Drugs and Medications 1–25 of 41

Possibly Relevant

Feiba [baxalta incorporated]

These highlights do not include all the information needed to use FEIBA safely and effectively. See full prescribing information for FEIBA. FEIBA, anti-inhibitor coagulant complex for intravenous use, lyophilized powder for solutionInitial U.S. Approval:

P32 sodium phosphate [anazaohealth corporation]

P32 Chromic Phosphate Suspension

Desmopressin acetate [sun pharmaceutical industries, inc.]

Desmopressin Acetate Injection, USP, 4 mcg/mL

Desmopressin acetate [sun pharmaceutical industries limited ]

Desmopressin Acetate Injection, USP, 4 mcg/mL

Desmopressin acetate [hospira, inc.]

Desmopressin Acetate Injection, USP

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

Desmopressin acetate [amring pharmaceuticals inc.]

DESMOPRESSIN ACETATE Injection4 mcg/mLRx only

Ddavp [ferring pharmaceuticals inc.]

DDAVP Injection (desmopressin acetate)

Desmopressin acetate [teva parenteral medicines, inc.]

Desmopressin Acetate Injection USP

Desmopressin acetate [sagent pharmaceuticals]

Desmopressin Acetate Injection, USPFor Intravenous or Subcutaneous Use Only

Desmopressin acetate [sagent pharmaceuticals]

Desmopressin Acetate Injection, USPFor Intravenous or Subcutaneous Use Only

Hemlibra [genentech, inc.]

These highlights do not include all the information needed to use HEMLIBRA safely and effectively. See full prescribing information for HEMLIBRA. HEMLIBRA (emicizumab-kxwh) injection, for subcutaneous use Initial U.S. Approval: 2017

Tranexamic acid [nexus pharmaceuticals inc]

NA

Stimate [csl behring llc]

Stimate (desmopressin acetate) Nasal Spray, 1.5 mg/mL

Tranexamic acid [heritage pharmaceuticals inc.]

Antifibrinolytic agent

Tranexamic acid [akorn, inc.]

Tranexamic acid [methapharm inc.]

NA

Fuzeon [genentech, inc.]

These highlights do not include all the information needed to use FUZEON safely and effectively. See full prescribing information for FUZEON. FUZEON (enfuvirtide) for Injection Initial U.S. Approval: 2003

Tranexamic acid [acella pharmaceuticals]

NA

Tranexamic acid [american regent, inc.]

TRANEXAMIC ACID INJECTION

Tranexamic acid [akorn, inc.]

TRANEXAMIC ACID INJECTION

Tranexamic acid [x-gen pharmaceuticals, inc.]

Tranexamic Acid Injection

Tranexamic acid [akorn, inc.]

TRANEXAMIC ACID INJECTIONAntifibrinolytic agent



Advertisement
Quick Search
Advertisement
Advertisement